164 related articles for article (PubMed ID: 15930715)
1. [Antiresorptive therapy for osteoporosis and bone quality].
Kishimoto H
Clin Calcium; 2005 Jun; 15(6):1007-11. PubMed ID: 15930715
[TBL] [Abstract][Full Text] [Related]
2. [Bisphosphonate therapy for osteoporosis and bone strength].
Kishimoto H
Clin Calcium; 2006 Sep; 16(9):1513-19. PubMed ID: 16951477
[TBL] [Abstract][Full Text] [Related]
3. [Effects of antiresorptive therapy on the structural and material properties of bone strength].
Kishimoto H
Clin Calcium; 2016 Jan; 26(1):107-15. PubMed ID: 26728537
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of bone quality. Bone quality and osteoporosis treatment].
Mashiba T
Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
[TBL] [Abstract][Full Text] [Related]
5. [Functional mechanism of glucocorticoid in bone turnover and bone structure].
Ikeda S; Akahoshi S; Sakai A; Nakamura T
Clin Calcium; 2006 Nov; 16(11):1805-11. PubMed ID: 17079846
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging therapies for osteoporosis.
Mitchner NA; Harris ST
J Fam Pract; 2009 Jul; 58(7 Suppl Osteoporosis):S45-9. PubMed ID: 19825319
[TBL] [Abstract][Full Text] [Related]
7. Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography.
Borah B; Dufresne TE; Ritman EL; Jorgensen SM; Liu S; Chmielewski PA; Phipps RJ; Zhou X; Sibonga JD; Turner RT
Bone; 2006 Aug; 39(2):345-52. PubMed ID: 16571382
[TBL] [Abstract][Full Text] [Related]
8. The roles of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy.
Epstein S
Mayo Clin Proc; 2005 Mar; 80(3):379-88. PubMed ID: 15757020
[TBL] [Abstract][Full Text] [Related]
9. Bone mineralization density distribution in health and disease.
Roschger P; Paschalis EP; Fratzl P; Klaushofer K
Bone; 2008 Mar; 42(3):456-66. PubMed ID: 18096457
[TBL] [Abstract][Full Text] [Related]
10. [Effects of vitamin D on bone quality].
Azuma Y; Harada Y; Ishizuka S; Kamimura T
Clin Calcium; 2004 Apr; 14(4):612-20. PubMed ID: 15577020
[TBL] [Abstract][Full Text] [Related]
11. The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future.
Davison KS; Siminoski K; Adachi JD; Hanley DA; Goltzman D; Hodsman AB; Josse R; Kaiser S; Olszynski WP; Papaioannou A; Ste-Marie LG; Kendler DL; Tenenhouse A; Brown JP
Semin Arthritis Rheum; 2006 Aug; 36(1):10-21. PubMed ID: 16887464
[TBL] [Abstract][Full Text] [Related]
12. [How do bisphosphonates improve bone quality?].
Takeuchi Y
Clin Calcium; 2004 Apr; 14(4):627-31. PubMed ID: 15577022
[TBL] [Abstract][Full Text] [Related]
13. [Bone quality and raloxifene].
Nakamura T
Clin Calcium; 2004 Apr; 14(4):632-7. PubMed ID: 15577023
[TBL] [Abstract][Full Text] [Related]
14. Histomorphometric analysis of glucocorticoid-induced osteoporosis.
Dalle Carbonare L; Bertoldo F; Valenti MT; Zenari S; Zanatta M; Sella S; Giannini S; Cascio VL
Micron; 2005; 36(7-8):645-52. PubMed ID: 16243531
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of bone loss and gain in untreated and treated osteoporosis.
Compston J
Endocrine; 2002 Feb; 17(1):21-7. PubMed ID: 12014699
[No Abstract] [Full Text] [Related]
16. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
17. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
[TBL] [Abstract][Full Text] [Related]
18. [The interplay of magnesium and vitamin K2 on bone mineralization].
Amizuka N; Li M; Maeda T
Clin Calcium; 2005 Jul; 15(7):57-61. PubMed ID: 15995297
[TBL] [Abstract][Full Text] [Related]
19. Emerging concepts in osteoporosis and bone strength.
Rubin CD
Curr Med Res Opin; 2005 Jul; 21(7):1049-56. PubMed ID: 16004672
[TBL] [Abstract][Full Text] [Related]
20. Fluoride and bone mineralization: an important issue in dentistry.
Frachella JC
ASDC J Dent Child; 1984; 51(6):417-21. PubMed ID: 6094629
[No Abstract] [Full Text] [Related]
[Next] [New Search]
